| Drug Name: | Piperazine (110-85-0) |
|---|---|
| PubChem ID: | 4837 |
| SMILES: | C1CNCCN1 |
| InchiKey: | GLUUGHFHXGJENI-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 86.138 |
| LogP | : | -0.8208 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 24.06 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Chlorpromazine (50-53-3) | Convulsions | Antagonistic | Not fully understood | Reaction between paperazine and chlorpromazine |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|